Indrayani Biotech Limited has approved the Basis of Allotment for its Rights Issue of Equity Shares. The Committee has finalized the allotment of 83,64,036 Rights Equity Shares. Of these, 75,03,333 shares were fully paid at Rs. 15 (including a Rs. 5 premium), and 8,60,703 shares were partly paid at Rs. 3.75 (including a Rs. 1.25 premium). This allotment has increased the company’s paid-up equity share capital.
Indrayani Biotech Finalizes Rights Issue Allotment
Indrayani Biotech Limited has announced the outcome of its Rights Issue Committee meeting held on November 03, 2026. The committee has considered and approved the Basis of Allotment for the company’s Rights Issue of Equity Shares.
Key Allotment Details
The approved Basis of Allotment covers 83,64,036 Rights Equity Shares. Specifically, 75,03,333 shares have been fully paid at an issue price of Rs. 15 per share, which includes a premium of Rs. 5. Additionally, 8,60,703 shares have been partly paid at Rs. 3.75 per share, including a premium of Rs. 1.25 on application. The committee confirmed that the Basis of Allotment was finalized in consultation with the Designated Stock Exchange, BSE Limited, which provided its approval via email on November 02, 2026.
Impact on Equity Capital
As a result of this allotment, Indrayani Biotech’s paid-up equity share capital has seen an increase. The company’s share capital has risen from 4,55,36,256 fully paid-up equity shares to 5,30,39,589 fully paid-up Equity Shares, along with 8,60,703 partly paid-up Equity Shares.
Meeting Information
The Rights Issue Committee meeting commenced at 4:30 pm and concluded at 5:30 pm on November 03, 2026.
Source: BSE
